FOLFIRI-Ramucirumab Regimen

Preferred Label : FOLFIRI-Ramucirumab Regimen;

NCIt synonyms : FOLFIRI Plus Cyramza; Folinic Acid/Fluorouracil/Irinotecan/Ramucirumab; FOLFIRI/Ramucirumab; FOLFIRI/Cyramza; FOLFIRI/Cyramza Regimen; FOLFIRI-Ramucirumab; FOLFIRI/Ramucirumab Regimen; FOLFIRI-Cyramza; FOLFIRI-Cyramza Regimen; FOLFIRI Plus Ramucirumab;

NCIt related terms : FOLFIRI and Ramucirumab;

NCIt definition : A regimen consisting of leucovorin, fluorouracil and irinotecan (FOLFIRI), plus ramucirumab that is used for the treatment of appendiceal adenocarcinoma, colon, esophageal and esophagogastric junction, gastric and rectal cancers.;

NCI Metathesaurus CUI : CL523562;

Codes from synonyms : 14991;

Détails

Origin ID

C136251;

UMLS CUI

C4526524;

Est indiqué pour
- Colorectal cancer metastatic [MedDRA Preferred Term]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Fluorouracil [NCIt concept]
- Irinotecan Hydrochloride [NCIt concept]
- Leucovorin Calcium [NCIt concept]
- Ramucirumab [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
regimen_has_accepted_use_for_disease
- Colorectal Carcinoma [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients